Skip to content
SearchSphereSource
Sign inSign up

Avesta Ketamine and Wellness

The Deal

Bought By
Deborah Tan
Year
Not published by any primary source
One backer's investments list carries the company against 2023, which is the backer's date, and its partners page dates only the start of its partnership with her, 2021. The company's own timeline runs to 2024 and records no sale, and its releases of February 2025, September 2025 and April 2026 name her co-chief executive without dating when she took the seat. An archived copy of its team page from October 2023 calls the founder co-chief executive and does not name her. No Form D in the SEC's quarterly data from 2020 to mid-2026 names her as a related person, and none is filed under her vehicle or the company.
Vehicle
Founder Focused Capital, backed by Endurance Search Partners and Novidam
Kind
Healthcare

A group of ketamine clinics in Washington, D.C., Maryland and Virginia treating depression, anxiety, PTSD and chronic pain with infusions and Spravato, founded in 2018 by a former Georgetown professor who led its nurse anesthesia program and remains Avesta's co-chief executive.

What Happened Next

Run by her and its founder as co-chief executives, by the company's own team page and its April 2026 release opening a fifth clinic. One backer carries it as a current investment of 2023, and no page read says she bought it.

The exit ends of journeys like this one, where the buyer has announced the purchase itself, are on Buyers.

Backed by the Same Firms

Endurance Search Partners

Novidam

Method & Source

This record is double-sourced: it joined when the purchase and, where the company has traded on, the exit could both be read in primary accounts rather than inferred.